top of page
Edison R Velastegui Suquillo
Admin
Life Sciences Professional | Industry Advisor |
More actions
Profile
Join date: Nov 25, 2025
Posts (6)
Feb 2, 2026 ∙ 3 min
When FDA Warning Letters Stop Being Surprises: Why Predictive Compliance Is Becoming Essential
TL;DR FDA enforcement in 2024–2025 is exposing systemic failures in complaint handling, CAPA, and investigations. These are not isolated issues, they are the predictable outcome of reactive quality architectures. Predictive compliance is emerging as the practical business response, not a theoretical upgrade. Life sciences organisations are entering a new phase of regulatory scrutiny. Recent FDA warning letters are no longer focused on missing documents or isolated procedural gaps. Instead,...
23
0
Jan 21, 2026 ∙ 3 min
From Reactive Compliance to Predictive Intelligence: Toward a Business Case
From Reactive Compliance to Predictive Intelligence: Toward a Business Case
19
0
Jan 20, 2026 ∙ 3 min
FDA Warning Letters Are Telling Us Something: Reactive Compliance Is No Longer Enough
FDA Warning Letters Are Telling Us Something: Reactive Compliance Is No Longer Enough
5
0
bottom of page